Fundraising Archives

Latest Posts

News and Trends 14 Feb 2020

Italian Investment Firm AurorA Science Launches to Support Early Stage Biotechs

Italian technology transfer company AurorA-TT has joined forces with drug discovery companies Rottapharm Biotech and Italfarmaco to launch the biotech investment enterprise AurorA Science to support early stage biotechs. The…

February 14, 2020 - 2 minutesmins - By Laura Cowen

In Depth 11 Feb 2020

Why European Biotechs Should Look to China for Investment

Traditionally European biotechs have looked to the US for additional investment, but changes in the law and significant economic success in the country in recent years means that new opportunities…

February 11, 2020 - 8 minutesmins - By Helen Albert

Expert Advice 15 Jan 2020

How to Spot a Biotech Winner: Investment Lessons from Sofinnova

Making one biotech a success is hard enough, but correctly predicting multiple winners is the bread and butter of Antoine Papiernik, Managing Partner of Sofinnova Partners, one of the biggest…

January 15, 2020 - 10 minutesmins - By Helen Albert

How to Make Healthcare Investments Accessible to the Public?

Early-stage investments in the healthcare sector are often dominated by public money, which is directly or indirectly provided by state institutions. But private investments are now being supported by the…

November 11, 2019 - 7 minutesmins - By Larissa Warneck-Silvestrin

Interview 8 Oct 2019

Biotech Hubs: A Tale of Two Cities

Life science investors differ widely across biotech hubs in Europe. At Labiotech’s recent Refresh event, two investors from Cambridge and Paris compared the progress of these hubs and discussed the…

October 8, 2019 - 6 minutesmins - By Jonathan Smith

Opinion 30 Sep 2019

Can European Biotech Companies Afford Not to Work with China?

In the current trade standoff between the US and China, Europe has a golden opportunity to gain a competitive advantage. At every healthcare conference I’ve been to recently in the…

September 30, 2019 - 4 minutesmins - By Antoine Papiernik

Opinion 16 Jul 2019

The Business of Biotech: What to Do When the S*#t Hits the Fan

From CEO-itis to FDA-itis, the path of a biotech company is never dull. Whether the oft-repeated saying, “may you live in interesting times,” is a blessing or a curse depends…

July 16, 2019 - 5 minutesmins - By Antoine Papiernik

Beyond Biotech - the podcast from Labiotech

View More

Newsletter Signup - Sidebar

"*" indicates required fields

Resources

Categories

The latest news on

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

Americas

Asia Pacific

Europe

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Company

Join Us

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering